The current treatments for children with multiple sclerosis (MS) was a theme explored in a session at this year’s conference of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), which took place on the 26th–28th October 2022. The speakers shared their insights into the management and clinical consequences of MS in children, and discussed perspectives as to why immunomodulatory treatment is different in children with MS.

With Moderna pledging not to enforce its COVID-19 vaccine patent in 92 LMICs, a hub in South Africa is pushing ahead with replication. Read for more details.

Exploring the mechanisms of action of Tumour Treating Fields (TTFields) therapy, this infographic highlights how TTFields selectively target and disrupt the progression of cancer cells.

The pandemic has exacerbated already troubling trends in the market access but has also created an opportunity for change in how drugs are priced and procured.

ROBOTIC liver resection has better perioperative tolerability compared to open liver resection, according to a new cohort study…

ARTIFICIAL intelligence can detect more than 80% of liver cancers through blood testing technology, according to a new study…

Preclinical studies have discovered that certain antibodies can alter the sugar composition of the gut, impacting microbes that reside there…

New research has indicated that gene variants associated with leukaemia, can produce ‘rogue’ immune cells that drive autoimmune diseases…

Obstructive HCM is a condition in which the heart has thickened walls that are not caused by blockage of the heart valves or by very high blood pressure. For the majority of patients, the cause of their disease has a genetic basis and is hereditary. A genetic test can diagnose HCM in some patients, but the results are inconclusive in others.